PMDA initiatives to enhance drug development via multi-regional clinical trials

Yasuto Otsubo · 2024

Read PMDA initiatives to enhance drug development via multi-regional clinical trials by Yasuto Otsubo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11711392.txt.

Description

Yasuto Otsubo outlines steps by Japan's drug agency to boost drug development through trials run in many regions at once, in a 2024 commentary. Japan faces drug lag, where drugs reach patients late, and drug loss, where drugs are never developed there at all. Dozens of drugs approved in Europe and the United States by 2020 had no Japanese approval by 2023.

The agency backs multi region trials so Japan joins global tests from the start. It also aids drugs for children and for rare or hard to treat diseases. One change rethinks when an early phase trial in Japanese subjects is truly needed. The piece sums up recent agency moves on each front.

Catalog record

CREATORYasuto Otsubo
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE9 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11711392

Browse the full library · About the Tower of Babel